IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

DE COBELLI, OTTAVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 26.265
AS - Asia 18.206
NA - Nord America 16.320
SA - Sud America 1.841
AF - Africa 448
OC - Oceania 130
Continente sconosciuto - Info sul continente non disponibili 13
Totale 63.223
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.730
DE - Germania 12.696
SG - Singapore 5.697
CN - Cina 5.507
GB - Regno Unito 3.468
IT - Italia 3.438
HK - Hong Kong 1.807
RU - Federazione Russa 1.576
SE - Svezia 1.523
BR - Brasile 1.377
VN - Vietnam 1.311
BD - Bangladesh 1.074
FR - Francia 963
IN - India 900
IE - Irlanda 553
NL - Olanda 506
FI - Finlandia 382
TR - Turchia 360
CA - Canada 340
KR - Corea 331
ID - Indonesia 287
JP - Giappone 258
UA - Ucraina 239
CI - Costa d'Avorio 179
DK - Danimarca 155
AR - Argentina 139
MX - Messico 125
ES - Italia 121
AU - Australia 119
AT - Austria 113
PH - Filippine 110
PL - Polonia 100
EU - Europa 91
IQ - Iraq 88
CO - Colombia 77
BE - Belgio 75
ZA - Sudafrica 70
EC - Ecuador 68
GR - Grecia 65
PK - Pakistan 60
CH - Svizzera 56
MA - Marocco 49
CL - Cile 48
PE - Perù 40
VE - Venezuela 37
EG - Egitto 36
SA - Arabia Saudita 34
UZ - Uzbekistan 34
MY - Malesia 33
PT - Portogallo 32
AE - Emirati Arabi Uniti 31
IR - Iran 28
JO - Giordania 28
KE - Kenya 28
TH - Thailandia 28
NO - Norvegia 27
TW - Taiwan 27
RO - Romania 26
CZ - Repubblica Ceca 23
PY - Paraguay 23
AZ - Azerbaigian 22
NP - Nepal 22
IL - Israele 21
CR - Costa Rica 20
TN - Tunisia 20
UY - Uruguay 20
KZ - Kazakistan 18
TT - Trinidad e Tobago 18
JM - Giamaica 17
LT - Lituania 16
NG - Nigeria 15
EE - Estonia 14
ET - Etiopia 13
AL - Albania 12
BO - Bolivia 11
DO - Repubblica Dominicana 10
GT - Guatemala 10
HN - Honduras 10
LU - Lussemburgo 10
OM - Oman 10
PS - Palestinian Territory 10
BY - Bielorussia 9
HU - Ungheria 9
KG - Kirghizistan 9
LB - Libano 9
RS - Serbia 9
BG - Bulgaria 8
HR - Croazia 8
MK - Macedonia 8
NZ - Nuova Zelanda 8
PA - Panama 8
SK - Slovacchia (Repubblica Slovacca) 8
AM - Armenia 7
SC - Seychelles 7
BH - Bahrain 6
GE - Georgia 6
NI - Nicaragua 6
CU - Cuba 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CY - Cipro 4
Totale 63.203
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 11.672
Singapore 3.050
Southend 2.991
Ashburn 2.005
Hong Kong 1.533
San Jose 1.244
Chandler 1.168
Milan 1.024
Beijing 981
Dallas 979
Seattle 648
Council Bluffs 633
Hefei 575
Princeton 572
Dublin 549
Los Angeles 504
Fairfield 467
Wilmington 451
New York 430
Ho Chi Minh City 383
Santa Clara 365
Lauterbourg 360
Bengaluru 351
Houston 335
Buffalo 326
Hanoi 312
Moscow 273
Guangzhou 240
Rome 218
Ann Arbor 217
Woodbridge 211
Des Moines 210
Nanjing 208
Jakarta 195
Cambridge 189
Abidjan 179
Dearborn 172
Mountain View 172
Munich 165
Shanghai 165
Tokyo 160
Columbus 156
Helsinki 152
Redmond 145
São Paulo 137
Phoenix 130
Berlin 126
Cangzhou 121
Seoul 115
Boardman 114
Jinan 114
The Dalles 112
Tianjin 107
Jacksonville 102
Istanbul 99
Changsha 93
Shenyang 93
Naples 92
Toronto 92
Chicago 82
Turin 82
London 78
Montreal 75
Nuremberg 74
Sakarya 74
Hyderabad 68
Redwood City 64
Shenzhen 63
Brussels 60
Orem 60
Haiphong 58
Athens 57
Washington 57
Eitensheim 56
Nanchang 56
Hebei 55
Turku 55
Hangzhou 53
Warsaw 53
Grafing 52
Mumbai 52
Vienna 52
San Diego 51
Atlanta 50
Somerville 49
Zhengzhou 49
Bologna 48
Bogotá 46
Da Nang 46
Fuzhou 46
Amsterdam 44
Rio de Janeiro 44
Andover 42
Dong Ket 42
Silver Spring 42
Bari 40
Ottawa 40
Lappeenranta 38
Dhaka 36
Brooklyn 35
Totale 41.206
Salva come PNG Salva come JPEG
Nome #
Perioperative outcomes of robotic and laparoscopic simple prostatectomy: a European-American multi-institutional analysis 639
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 580
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 467
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer : a histology-validated study including 301 operated patients 416
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 387
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 387
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) : inter-observer agreement between readers of different expertise levels 358
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 343
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 338
Prostatectomia radicale robotica in presenza di un voluminoso lobo medio 336
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) 329
Predicting trajectories of recovery in prostate cancer patients undergone Robot-Assisted Radical Prostatectomy (RARP) 328
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 323
Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy 317
Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer 313
No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapy 309
Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer 301
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration 300
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml 296
Contemporary rates and predictors of open conversion during minimally invasive radical prostatectomy for non-metastatic prostate cancer 296
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 294
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 290
CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study 289
Evoluzione della tecnica di ricostruzione posteriore dello sfintere striato dopo prostatectomia radicale robotica 289
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 289
[11C]Choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy 288
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218) 287
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 287
Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis 284
High-performance prediction models for prostate cancer radiomics 283
Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies : Time to Improve Radiologists’ Training Program? 280
Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study 277
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach 276
Metabolic syndrome predicts worse perioperative outcomes in patients treated with partial nephrectomy for renal cell carcinoma 261
Long-term follow‐up outcomes after percutaneous us/ct‐guided radiofrequency ablation for ct1a‐b renal masses : Experience from single high‐volume referral center 259
Anterior prostatic tumours are difficult to diagnose without MRI 258
Late toxicity of image-guided hypofractionated radiotherapy for prostate : non-randomized comparison with conventional fractionation 257
Robot-assisted radical prostatectomy : multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical margins 257
Robot-assisted simple prostatectomy (RASP) : does it make sense? 255
Chronic bacterial prostatitis : efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®) 252
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging 251
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy 248
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 248
Robot assisted radical prostatectomy in kidney transplant recipients: surgical, oncological and functional outcomes of two different robotic approaches 247
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3) 246
A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor 244
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up 242
Exploring mirna signature and other potential biomarkers for oligometastatic prostate cancer characterization: The biological challenge behind clinical practice : a narrative review 240
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 239
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling 238
Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion : ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218 236
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 233
A novel "intuitive" surgical technique for right robot-assisted retroperitoneal lymph node dissection for stage I testicular NSGCT 232
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 232
Robotic vs open prostatectomy in a laparoscopically naive centre: a matched-pair analysis 231
Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience 230
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancer 230
Robot-assisted intracorporeal orthotopic ileal neobladder : Description of the “shell” technique 230
External validation of EORTC risk scores to predict recurrence after transurethral resection of brazilian patients with non -muscle invasive bladder cancer stages Ta and T1 229
Surgical blood loss during holmium laser enucleation of the prostate (HoLEP) is not affected by short-term pretreatment with dutasteride: A double-blind placebo-controlled trial on prostate vascularity 229
Penile-Sparing Surgery for Tumour Recurrence after Previous Glansectomy/Partial Penectomy: Treatment Feasibility and Oncological Outcomes 227
Quality of life and psycho-emotional wellbeing in bladder cancer patients and their caregivers: A comparative analysis between urostomy versus ileal orthotopic neobladder 225
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome 224
Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy 222
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance 221
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 221
Quality assurance for automatically generated contours with additional deep learning 220
Effetto della curva di apprendimento di un Gruppo Laparoscopic Naive sui risultati oncologici e funzionali della prostatectomia radicale robot assisted 220
Impact of surgical approach and resection technique on the risk of Trifecta Failure after partial nephrectomy for highly complex renal masses 218
Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer 218
Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy : the value of prostate cancer antigen 3 (PCA3), prostate health index (Phi) and sarcosine 218
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer 217
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 217
Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy : preliminary report 216
Validation of the 2009 TNM Version in a large multi-institutional cohort of patients treated for renal cell carcinoma : are further improvements needed? 216
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? 216
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol 215
Predicting Peri-Operative Outcomes in Patients Treated with Percutaneous Thermal Ablation for Small Renal Masses: The SuNS Nephrometry Score 214
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation 214
Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomy 214
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 213
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center 213
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases 212
Beyond PSA : The role of prostate health index (phi) 210
Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer : Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study 207
Robot-assisted Resection of a Wide-extending Abdominoperineal Angiomyofibroblastoma in a Male Patient 206
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 206
Thulium–yttrium–aluminium–garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life 206
Apparent Diffusion Coefficient and Other Preoperative Magnetic Resonance Imaging Features for the Prediction of Positive Surgical Margins in Prostate Cancer Patients Undergoing Radical Prostatectomy 206
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 205
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort 205
Radiotherapy in prostate cancer patients with pelvic lymphocele after surgery: clinical and dosimetric data of 30 patients 204
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 203
Neoadjuvant chemotherapy for invasive bladder cancer : an interesting case report 203
"Burned out" phenomenon of the testis in retroperitoneal seminoma 202
Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study 201
Postoperative vacuum therapy following AMS™ LGX 700® inflatable penile prosthesis placement: penile dimension outcomes and overall satisfaction 200
Sexual function recovery after robot-assisted radical prostatectomy : outcomes from an Italian referral centre and predicting nomogram 200
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion : a plan comparison 200
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities 199
Totale 26.104
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021624 0 0 0 0 0 0 0 0 0 0 419 205
2021/20223.475 197 190 129 171 329 307 220 245 282 295 261 849
2022/20234.738 642 453 417 448 417 816 248 307 527 64 296 103
2023/202410.707 160 239 174 197 728 397 1.712 1.523 740 1.452 1.678 1.707
2024/202512.971 1.572 1.592 1.308 1.149 676 602 459 996 515 860 1.037 2.205
2025/202621.630 2.276 1.800 2.502 1.897 1.830 1.285 2.519 1.080 2.128 1.507 2.806 0
Totale 65.630